TUYEN NGO: Open Payments
NPI 1710416748 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,706 in 129 payments from 20 companies in 2025. Trend: 2023 $722 · 2024 $1,830 · 2025 $2,706
Food & beverage: $2,687Education: $18
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 34 | $543 |
| ABBVIE INC. | 20 | $376 |
| Madrigal Pharmaceuticals | 9 | $332 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $304 |
| Ipsen Biopharmaceuticals, Inc | 6 | $158 |
| QOL Medical, LLC | 6 | $150 |
| Ardelyx, Inc. | 7 | $136 |
| Regeneron Healthcare Solutions, Inc. | 4 | $127 |
| Celltrion USA Inc. | 5 | $98 |
| Phathom Pharmaceuticals, Inc. | 5 | $82 |
Products named: TREMFYA, REZDIFFRA, ENTYVIO, DUPIXENT, Sucraid, IBSRELA, RINVOQ, LINZESS.
Industry payments across NY — which companies pay providers there.
